Calm/Storm Ventures

Calm/Storm Ventures is a boutique venture capital firm and exclusive founder network focused on investing in purpose-driven founders within the digital health and wellbeing sectors across Europe and the US. Their mission centers on backing startups that address taboo or sensitive health topics with large market potential, emphasizing diversity and equal opportunity by supporting underrepresented minorities. They invest primarily at the super-early stage, often participating in founders' first fundraising rounds, and foster a community where founders support each other through shared expertise and collaboration. Their portfolio spans a wide range of health tech innovations, from fertility and mental health to AI-enabled clinical decision support and chronic disease management, making them the most active healthtech investor in Europe[1][2][6].

Founded in Vienna, Austria, Calm/Storm Ventures was established around 2019 and is led by key partners including Lucanus Polagnoli (Founding Partner & CEO), Michael Sträck, and others. The firm evolved with a strong operator-first and data-driven approach, leveraging extensive venture capital experience to identify and nurture early-stage companies in health tech and wellbeing. Their focus on taboo health topics and commitment to diversity has shaped their investment thesis and portfolio composition, with over 50% of portfolio founders coming from underrepresented backgrounds and a significant share of female leadership[1][2][7].

Core Differentiators

• Unique Investment Model: Super-early stage focus, investing often at idea or prototype phases, with flexible entry even without a final co-founder team or pitch deck.
• Founder Network: An exclusive community where founders support each other, facilitated by "Supporting Partners" who provide operational and strategic guidance.
• Diversity Commitment: Over 50% of portfolio companies have diverse teams; strong emphasis on gender balance and minority representation.
• Sector Expertise: Deep specialization in digital health and wellbeing, including taboo and underserved health markets.
• Geographic Reach: Investments across North America and multiple European countries including Germany, Austria, UK, France, and Israel[1][2][3].

Role in the Broader Tech Landscape

Calm/Storm Ventures rides the growing global trend toward digital health innovation, particularly in areas historically neglected due to social stigma or complexity. The timing is critical as healthcare systems and consumers increasingly demand tech-enabled, accessible, and personalized health solutions. Market forces such as rising chronic disease prevalence, mental health awareness, and advances in AI and data analytics favor their investment thesis. By focusing on taboo health topics and diverse founders, Calm/Storm not only taps into large unmet needs but also helps broaden the inclusivity and impact of the healthtech ecosystem in Europe and beyond[1][2].

Quick Take & Future Outlook

Looking ahead, Calm/Storm Ventures is poised to deepen its leadership in European healthtech by continuing to back early-stage, high-impact startups that challenge norms and expand healthcare accessibility. Trends such as AI-driven diagnostics, personalized medicine, and mental health tech will likely shape their portfolio evolution. Their community-driven model and commitment to diversity position them to influence both financial returns and social impact, potentially setting new standards for inclusive venture capital in health innovation. As digital health adoption accelerates globally, Calm/Storm’s founder-centric approach and focus on taboo topics will remain a distinctive advantage in navigating the complex healthcare landscape[2][7].